MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
˜The œLancet. Gastroenterology & hepatology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

205 results · 1 filter active ·
Results by year
20162025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
205 works in the cohort · of 4,299,418page 3 of 5

Labels cover 0 of 205 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 205 of 205 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

fundno affunlabeled
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
Zhigang Liu, Kaixing Le, Xin Zhou, James L. Alexander, Simeng Lin, Claire Bewshea +677 more
2022· article· en· ˜The œLancet. Gastroenterology & hepatology· Medicine
machine prediction:candidate · noneconsensus · none
35
citations
affno abstractunlabeled
Precision surgery for hepatocellular carcinoma
Christian Tibor Josef Magyar, Luckshi Rajendran, Zhihao Li, Vanessa Banz, Arndt Vogel, Grainne M. O’Kane +2 more
2025· review· en· ˜The œLancet. Gastroenterology & hepatology· Medicine
machine prediction:candidate · noneconsensus · none
30
citations
affno abstractunlabeled
Probiotics and COVID-19
Éric Giannoni, David Baud, Varvara Dimopoulou Agri, Glenn R. Gibson, Gregor Reid
2020· letter· en· ˜The œLancet. Gastroenterology & hepatology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
23
citations
affno abstractunlabeled
Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials
Eric Lawitz, Marı́a Buti, John M. Vierling, Piero Luigi Almasio, Savino Bruno, Peter Ruane +23 more
2017· article· en· ˜The œLancet. Gastroenterology & hepatology· Medicine
machine prediction:candidate · noneconsensus · none
22
citations
affno abstractunlabeled
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
Silvio Danese, Jessica R. Allegretti, Stefan Schreiber, Laurent Peyrin‐Biroulet, Vipul Jairath, Geert D’Haens +14 more
2025· article· en· ˜The œLancet. Gastroenterology & hepatology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
15
citations
affno abstractunlabeled
Hepatitis C virus in sub-Saharan Africa: a long road to elimination
Rajiv Shah, Adwoah Agyei-Nkansah, Francis Alikah, Lucy Asamoah‐Akuoko, Yorou Chabi Orou Bagou, Abdirahman Dhiblawe +16 more
2021· letter· en· ˜The œLancet. Gastroenterology & hepatology· Medicine
machine prediction:candidate · noneconsensus · none
12
citations
affno abstractunlabeled
Ulcerative colitis: moving beyond the mucosal dogma
K Gecse, Noa Krugliak Cleveland, Frauke Petersen, João Sabino, André D’Hoore, Torsten Kucharzik +6 more
2025· review· en· ˜The œLancet. Gastroenterology & hepatology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
9
citations

How this was built: Screen · Findings · About